ResMed Inc (RMD) stock

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3012% below fair value

$239.53+0.64 (+0.27%)

Close on Nov 13, 2026Market cap $33.69BP/E 21.8Yield 1.00%

ResMed EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

ResMed's EV/EBITDA was 15.9× on Nov 11, 2026, against 18.6× a year earlier. Over the last 5 years it ranged from 12.4× to 34.1×, with a median of 21.5×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	15.9×	−1.6
2025	Dec 31, 2025	17.5×	−3.3
2024	Dec 31, 2024	20.8×	+1.8
2023	Dec 29, 2023	19.0×	−6.8
2022	Dec 30, 2022	25.9×	−8.2
2021	Dec 31, 2021	34.1×	+4.1
2020	Dec 31, 2020	30.0×	+1.1
2019	Dec 31, 2019	28.9×	+5.9
2018	Dec 31, 2018	23.1×	+1.1
2017	Dec 29, 2017	22.0×	+4.4
2016	Dec 30, 2016	17.5×	+2.8
2015	Dec 31, 2015	14.8×	−0.6
2014	Dec 31, 2014	15.4×	+1.8
2013	Dec 31, 2013	13.5×	+0.2
2012	Dec 31, 2012	13.4×	+3.6
2011	Dec 30, 2011	9.7×	−5.4
2010	Dec 31, 2010	15.2×	+0.4
2009	Dec 31, 2009	14.8×	–